[Schnitzler syndrome: A review of literature, the authors' observation, and experience with the interleukin-1 inhibitor canakinumab].
| Autor: | Salugina SO; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Gorodetsky VR; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Fedorov ES; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Lopatina NE; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Evsikova MD; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia. |
|---|---|
| Jazyk: | ruština |
| Zdroj: | Terapevticheskii arkhiv [Ter Arkh] 2017; Vol. 89 (11), pp. 111-115. |
| DOI: | 10.17116/terarkh20178911111-115 |
| Abstrakt: | The paper reviews the publications dealing with Schnitzler syndrome, a rare autoinflammatory disease, and describes the authors' own clinical observation. It describes the first Russian experience in successfully using the interleukin-1 inhibitor canakinumab to treat this disease. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|